CRISPR became big in 2025, bringing advances for serious Indian health risks, which will continue in the coming year ...

Radiation in deep space isn’t just dangerous — it’s colonization-ending. Even the best shielding fails on long trips, and a single day on Europa could kill you. NASA is already testing CRISPR gene ...

The EPA is the authority charged with regulating biosafety and genome editing. Its tasks include granting permits, conducting risk assessments, and overseeing compliance. On the other hand, the Bio ...

A dire wolf de-extinction debate, CRISPR-GPT for gene editing, and more topped the list of our most popular stories in ...

As of Tuesday, December 23, Editas Medicine, Inc.’s EDIT share price has dipped by 5.08%, which has investors questioning if this is right time to buy.

During infection, the human immunodeficiency virus (HIV) inserts itself into the host genome as a chromosomally-integrated provirus that persists in infected cells. Although antiretroviral therapies ...

The magnetic compass is the last unknown sense in migrating animals. For some scientists, the monarch butterfly is leading ...

Easing hot flashes, treating rare genetic diseases and a made-in-Canada vaccine among the year’s notable developments ...

Goldenberries have long been a niche curiosity, tucked into specialty produce aisles and health food shops while tomatoes and ...

An experimental gene therapy seems to slow the progression of Huntington’s disease by about 75 per cent, and researchers are ...

Now, Musunuru and colleagues are preparing a master clinical protocol to study a CRISPR therapy that's mostly the same as the one they used to treat baby KJ, except they plan to swap out the gene ...